Mansbach Jonathan M, Piedra Pedro A, Teach Stephen J, Sullivan Ashley F, Forgey Tate, Clark Sunday, Espinola Janice A, Camargo Carlos A
Department of Medicine, Children’s Hospital Boston, Boston 02115, USA.
Arch Pediatr Adolesc Med. 2012 Aug;166(8):700-6. doi: 10.1001/archpediatrics.2011.1669.
To determine whether hospital length of stay(LOS) for acute bronchiolitis is influenced by the infecting pathogen.
A prospective observational cohort study was performed during 3 consecutive years.
Sixteen US hospitals participated in the study.
Children younger than 2 years hospitalized with bronchiolitis were included.
The results of nasopharyngeal aspirate polymerase chain reaction pathogen testing served as the main exposure.
Hospital LOS was determined.
Of 2207 participants, 72.0% had respiratory syncytial virus (RSV) and 25.6% had human rhinovirus(HRV); the incidence of each of the other viruses and bacteria was 7.8% or less. Multiple pathogen infections were present in 29.8% of the children. There were 1866 children(84.5%) with RSV and/or HRV. Among these 1866 children, the median age was 4 months and 59.5% were male. The median LOS was 2 days (interquartile range,1-4 days). Compared with children who had only RSV,an LOS of 3 or more days was less likely among children with HRV alone (adjusted odds ratio [AOR], 0.36; 95%CI, 0.20-0.63; P.001) and those with HRV plus non-RSV pathogens (AOR, 0.39; 95% CI, 0.23-0.66; P.001)but more likely among children with RSV plus HRV(AOR,1.33; 95% CI, 1.02-1.73; P=.04), controlling for 15 demographic and clinical factors.
In this multicenter study of children hospitalized with bronchiolitis, RSV was the most common virus detected, but HRV was detected in one-quarter of the children. Since 1 in 3 children had multiple virus infections and HRV was associated with LOS, these data challenge the effectiveness of current RSV-based cohorting practices, the sporadic testing for HRV in bronchiolitis research, and current thinking that the infectious etiology of severe bronchiolitis does not affect short-term outcomes.
确定急性细支气管炎的住院时长是否受感染病原体的影响。
进行了一项为期3年的前瞻性观察队列研究。
16家美国医院参与了该研究。
纳入2岁以下因细支气管炎住院的儿童。
鼻咽抽吸物聚合酶链反应病原体检测结果作为主要暴露因素。
确定住院时长。
在2207名参与者中,72.0%感染呼吸道合胞病毒(RSV),25.6%感染人鼻病毒(HRV);其他病毒和细菌的感染率均为7.8%或更低。29.8%的儿童存在多种病原体感染。有1866名儿童(84.5%)感染了RSV和/或HRV。在这1866名儿童中,中位年龄为4个月,59.5%为男性。中位住院时长为2天(四分位间距,1 - 4天)。与仅感染RSV的儿童相比,仅感染HRV的儿童(校正优势比[AOR],0.36;95%置信区间[CI],0.20 - 0.63;P <.001)以及感染HRV加非RSV病原体的儿童(AOR,0.39;95% CI,0.23 - 0.66;P <.001)住院3天或更长时间的可能性较小,但感染RSV加HRV的儿童住院3天或更长时间的可能性较大(AOR,1.33;95% CI,1.02 - 1.73;P = 0.04),对15个人口统计学和临床因素进行了控制。
在这项针对因细支气管炎住院儿童的多中心研究中,RSV是检测到的最常见病毒,但四分之一的儿童检测到HRV。由于三分之一的儿童存在多种病毒感染且HRV与住院时长相关,这些数据对当前基于RSV的分组做法的有效性、细支气管炎研究中对HRV的零星检测以及当前认为严重细支气管炎的感染病因不影响短期结局的观点提出了挑战。